Large biopharma companies looking at China assets right now, says Goldman Sachs Salveen RichterOctober 6, 2026
The market is focused on the narrow portion of the AI trade, says Bartlett’s Holly MazzoccaOctober 6, 2026
Share Facebook Twitter LinkedIn Pinterest Email “Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” – CLICK HERE for the FULL deal. David Kostin, Goldman Sachs chief U.S. equity strategist, joins CNBC’s ‘Squawk on the Street’ to discuss market outlooks, how the market is pricing in uncertainty, and more.